Kenya ePrescription FHIR Implementation Guide - Local Development build (v0.1.0) built by the FHIR (HL7® FHIR® Standard) Build Tools. See the Directory of published versions
| Active as of 2026-04-24 |
@prefix fhir: <http://hl7.org/fhir/> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix rdf: <http://www.w3.org/1999/02/22-rdf-syntax-ns#> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
# - resource -------------------------------------------------------------------
a fhir:CodeSystem ;
fhir:nodeRole fhir:treeRoot ;
fhir:id [ fhir:v "condition-stage-cs"] ; #
fhir:text [
fhir:status [ fhir:v "generated" ] ;
fhir:div [ fhir:v "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: CodeSystem condition-stage-cs</b></p><a name=\"condition-stage-cs\"> </a><a name=\"hccondition-stage-cs\"> </a><p>This case-sensitive code system <code>https://ilm-hie.dha.go.ke/fhir/CodeSystem/condition-stage-cs</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td><td><b>Definition</b></td></tr><tr><td style=\"white-space:nowrap\">stage-0<a name=\"condition-stage-cs-stage-0\"> </a></td><td>Stage 0</td><td>In-situ disease; no invasion.</td></tr><tr><td style=\"white-space:nowrap\">stage-i<a name=\"condition-stage-cs-stage-i\"> </a></td><td>Stage I</td><td>Localised disease with minimal spread.</td></tr><tr><td style=\"white-space:nowrap\">stage-ii<a name=\"condition-stage-cs-stage-ii\"> </a></td><td>Stage II</td><td>Regional spread with limited involvement.</td></tr><tr><td style=\"white-space:nowrap\">stage-iii<a name=\"condition-stage-cs-stage-iii\"> </a></td><td>Stage III</td><td>Extensive regional spread.</td></tr><tr><td style=\"white-space:nowrap\">stage-iv<a name=\"condition-stage-cs-stage-iv\"> </a></td><td>Stage IV</td><td>Distant metastasis.</td></tr><tr><td style=\"white-space:nowrap\">stage-v<a name=\"condition-stage-cs-stage-v\"> </a></td><td>Stage V</td><td>Bilateral disease (used in paediatric oncology).</td></tr><tr><td style=\"white-space:nowrap\">occult-stage<a name=\"condition-stage-cs-occult-stage\"> </a></td><td>Occult stage</td><td>Tumour present but primary site unknown.</td></tr><tr><td style=\"white-space:nowrap\">not-staged<a name=\"condition-stage-cs-not-staged\"> </a></td><td>Not staged</td><td>Staging not performed or not applicable.</td></tr></table></div>"^^rdf:XMLLiteral ]
] ; #
fhir:url [
fhir:v "https://ilm-hie.dha.go.ke/fhir/CodeSystem/condition-stage-cs"^^xsd:anyURI ;
fhir:l <https://ilm-hie.dha.go.ke/fhir/CodeSystem/condition-stage-cs>
] ; #
fhir:version [ fhir:v "0.1.0"] ; #
fhir:name [ fhir:v "ConditionStageCS"] ; #
fhir:title [ fhir:v "Condition Stage CodeSystem"] ; #
fhir:status [ fhir:v "active"] ; #
fhir:date [ fhir:v "2026-04-24T09:57:31+00:00"^^xsd:dateTime] ; #
fhir:publisher [ fhir:v "DHA, Kenya"] ; #
fhir:contact ( [
fhir:name [ fhir:v "DHA, Kenya" ] ;
( fhir:telecom [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://dha.go.ke/" ] ] [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "helpdesk@dha.go.ke" ] ] )
] [
fhir:name [ fhir:v "Digital Health Agency, Kenya" ] ;
( fhir:telecom [
fhir:system [ fhir:v "email" ] ;
fhir:value [ fhir:v "helpdesk@dha.go.ke" ] ;
fhir:use [ fhir:v "work" ] ] [
fhir:system [ fhir:v "url" ] ;
fhir:value [ fhir:v "https://www.dha.go.ke/" ] ] )
] ) ; #
fhir:description [ fhir:v "Staging codes for oncology and other staged conditions. Source: MOH-KENYA OCL CONDITION-STAGE."] ; #
fhir:jurisdiction ( [
( fhir:coding [
fhir:system [
fhir:v "urn:iso:std:iso:3166"^^xsd:anyURI ;
fhir:l <urn:iso:std:iso:3166> ] ;
fhir:code [ fhir:v "KE" ] ;
fhir:display [ fhir:v "Kenya" ] ] )
] ) ; #
fhir:copyright [ fhir:v "Copyright 2025+ Digital Health Agency, Kenya. This content is licensed under Creative Commons Attribution 4.0 International (CC-BY-4.0). Terminology content from the Kenya Pharmacy and Poisons Board (PPB) via Open Concept Lab (OCL) is subject to separate terms."] ; #
fhir:caseSensitive [ fhir:v true] ; #
fhir:content [ fhir:v "complete"] ; #
fhir:count [ fhir:v "8"^^xsd:nonNegativeInteger] ; #
fhir:concept ( [
fhir:code [ fhir:v "stage-0" ] ;
fhir:display [ fhir:v "Stage 0" ] ;
fhir:definition [ fhir:v "In-situ disease; no invasion." ]
] [
fhir:code [ fhir:v "stage-i" ] ;
fhir:display [ fhir:v "Stage I" ] ;
fhir:definition [ fhir:v "Localised disease with minimal spread." ]
] [
fhir:code [ fhir:v "stage-ii" ] ;
fhir:display [ fhir:v "Stage II" ] ;
fhir:definition [ fhir:v "Regional spread with limited involvement." ]
] [
fhir:code [ fhir:v "stage-iii" ] ;
fhir:display [ fhir:v "Stage III" ] ;
fhir:definition [ fhir:v "Extensive regional spread." ]
] [
fhir:code [ fhir:v "stage-iv" ] ;
fhir:display [ fhir:v "Stage IV" ] ;
fhir:definition [ fhir:v "Distant metastasis." ]
] [
fhir:code [ fhir:v "stage-v" ] ;
fhir:display [ fhir:v "Stage V" ] ;
fhir:definition [ fhir:v "Bilateral disease (used in paediatric oncology)." ]
] [
fhir:code [ fhir:v "occult-stage" ] ;
fhir:display [ fhir:v "Occult stage" ] ;
fhir:definition [ fhir:v "Tumour present but primary site unknown." ]
] [
fhir:code [ fhir:v "not-staged" ] ;
fhir:display [ fhir:v "Not staged" ] ;
fhir:definition [ fhir:v "Staging not performed or not applicable." ]
] ) . #
IG © 2025+ DHA, Kenya. Package fhir.eprescription.ig#0.1.0 based on FHIR 4.0.1. Generated 2026-04-24
Links: Table of Contents |
QA Report